Purpose: Levosimendan has been shown to have a better hemodynamic profile over dobutamine in increasing cardiac output and reducing pulmonary wedge pressure in patients with acute decompensated heart failure (HF). Data comparing the effect of levosimendan with dobutamine on systolic time intervals is lacking. Therefore, the aim of this study was to evaluate the effects of levosimendan and dobutamine on systolic time intervals. Methods: Fifty patients with NYHA class III-IV decompensated HF requiring inotropic support, LVEF <35% and in sinus rhythm were randomized (in a 1:1 design) to levosimendan (n¼25) or dobutamine (n¼25). Both inotropic agents were administered as a continuous 24-h infusion (levosimendan at a dose of 0.2 mgr/kg/min with a preceding bolus dose of 12 mgr/kg and dobutamine at a dose of 10 mgr/kg/min without a bolus dose). All patients underwent echocardiographic evaluation before and at the end of inotropic infusion. LVEF, heart rate-corrected electromechanical systole (QS2i), pre-ejection period (PEP) and left ventricular ejection time (LVET) were measured. Results: There was no significant difference in baseline clinical characteristics and laboratory parameters between levosimendan and dobutamine groups. As compared with their baseline values, LVEF and LVET significantly increased at the end of both levosimendan and dobutamine infusions with a similar extent in both groups (table) . Levosimendan significantly shortened QS2i and PEP. Dobutamine shortened PEP, but showed no effect on QS2i. Conclusıons: This study suggests that both levosimendan and dobutamine are almost equally effective in increasing LVET and in shortening PEP. However, levosimendan appears to have additional advantage over dobutamine in shortening QS2i, indicating a fairly strong positive inotropic effect.
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The Background: Warfarin use and associated outcomes in patients with chronic heart failure (HF) have not been well described previously. We hypothesized that warfarin is associated with lower risks of cardiovascular mortality in patients with sinus rhythm, atrial fibrillation and pacemaker rhythm. Methods: We examined the outcomes in patients who were followed -up between January 2003 and April 2011 in the out-patient clinic due to chronic HF. 671 HF patients were enrolled into the study group (427 male, 244 female, mean age, 64 AE 13 years; mean ejection fraction, 27 AE 12%, mean NYHA 2.8AE0.5, 62% with coronary artery disease). 445 patients had sinus rhythm, 165 patients had atrial fibrillation and 61 patients had pacemaker rhythm. Results: Two hundred -fifty three patients (38%) died due to cardiovascular reasons. 210 (31 %) patients were on warfarin treatment. However 27 patients (63%) who were not taken warfarin died, 39 patients (%32) who were taken warfarin died in atrial fibrillation (p<0.001) due to cardiovascular reasons during follow-up. Although 149 patients (40%) who were not on warfarin treatment died and 18 patients (24 %) who were on warfarin treatment died in sinus rhythm due to cardiovascular reasons during follow-up (p¼0.006). We did not find any statistical difference between patients with warfarin user and patients who were not user in patients with pacemaker rhythm. Conclusıon: It seemed patients who were taken warfarin had better outcomes in patients with atrial fibrillation and in patients with sinus rhythm in chronic HF.
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Depression Heart failure (HF) is a common disease worldwide. On the other hand, regular physical activity is beneficial in terms of outcomes. In this study, parameters which influence regular activity were investigated. 100 consecutive outpatients (age 65AE13 years, 54 males, 46 females) with stable systolic heart failure (31AE10% ejection fraction) were enrolled. All patients were asked for engagement with regular physical activity, and evaluated with Beck depression inventory (BDI). Results: 41 out of 100 patients stated that they engage regular physical activity with a median of 3 days per week (ranging from 1-7 days/week). In the univariate analysis, absence of regular physical activity was associated with female gender, lower ejection fraction (EF), higher NYHA functional class, nonischemic etiology, presence of therapy with spironolactone, higher BNP, BUN, longer duration of HF, lower plasma sodium, higher tricuspid annular excursion (Table 1) . Patients were classified into two as those with presence of at least mild depression (BDI score !14) versus those without depression. It was found that at least mild form of depression (BDI !14) was found in 36.6% of patients having regular physical activity whereas, depression was present in 88.1% of patients not having regular physical activity. Of note, severe depression (BDI !29) was present in 7.3% and 49.2% respectively. Beck depression score was able to predict absence of engagement in regular physical activity in patients with HF (AUC¼0.827, p<0.001). In the stepwise regression analysis, it was found that female gender (p¼0.010, ExpB¼4.251, 95%CI:1.417-12.751), having at least mild depression by BDI (p¼0.0.10, ExpB¼4.639 95% CI:1.451-14.829) and EF (p¼0.017, ExpB¼0.928, 95% CI:0.873-0.986) were found to be independent predictors of absence of regular physical activity in stable outpatients with systolic HF. Conclusıon: Depression could potentially influence engagement in regular physical activity in outpatients with systolic HF.
Data of the patients with systolic heart failure before and after vitamin D supplementation Aim: The prognostic significance of patients with heart failure complicated with pleural effusions determined by means of echocardiography is lacking. Thus we sought to determine the prognostic significance of hematologic parameters at heart failure patients with pleural effusion which was evaluated incidentally during echocardiographic evaluation.
Methods: Between Jan 2002 and Dec 2012, total 151 patients with heart failure suffered from pleural effusion analysed. All patients mortality data are derived from registry center of Social Insurance Institution which officially responsible for recording all mortality data in Turkey. The diagnosis of patients' pleural effusion status were made during echocardiographic evaluation. We also evaluated hematological parameters including creatinine, uric acid, albumin, sodium, potassium, hemoglobin at the time of hospital admission. Kaplan-Meir survival rates were determined and subgroups were compared with log-rank test and Chi-square test. Results: Total 151 eligible patients were analysed. Mean age was 60AE16.Male/ Female ratio was 97/54. Mean duration of follow-up was 71.5 AE 45.6 months. Fiftyone patients (33.8%) died during this follow-up period. There was not a significant difference regarding age and sex between survivors and those had died during followup. There were no prognostic significance of creatinine, uric acid, and potassium levels. (p>0.05). However, albumin, sodium and hemoglobin levels were associated with poor prognosis (p<0.0001, p¼0.001, and p¼0.009, respectively). Conclusıon: Blood albumin, sodium, and hemoglobin levels have a worse prognostic significance in patient with heart failure complicated with pleural effusion determined by means of echocardiography.
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Even Background: Recent findings suggest that there is a close relationship between chronic heart failure and uric acid (UA). UA is the final product of purine metabolism in humans and is implicated in many disease conditions. Sustained hyperuricaemia has putative adverse roles in cardiovascular diseases. It was determined that elevated UA levels could be a risk factor for cardiac dysfunction. Increased serum uric acid levels may be an important prognostic marker in chronic heart failure (CHF). Methods: A total of 593 CHF patients with measured UA levels, creatinine levels, urea levels, BNP levels and hs-CRP levels, ejection fraction between May 2003 and January 2009 were evaluated, (382 males, 211 females mean age 63AE13 years, mean ejection fraction 26AE10 %, mean New York Heart Association (NYHA) class 2.8AE0.5). Mean UA level was 7.5AE2.6 mg/dL. While 64% of patients had coronary artery disease (CAD), 26 % patients had chronic renal disease (CRD). The cardiovascular death was accepted as an endpoint. Results: 36% of patients were died due to cardiovascular reason in this group. Patients who met end point criteria was older and had higher NYHA class, urea levels, BNP levels, hs-CRP levels, UA levels, lower ejection fraction, increased right ventricular (RV) dimension and higher pulmonary artery pressure. In multivariate analysis, when UA levels were adjusted for a second parameters (age, gender, NYHA, CAD, CRD, urea, hs-CRP, RV), the risk of death remained significant after each adjustment. Moreover, age (hazard ratio (HR): 1.055, 95%CI: 1.035-1.075, p<0.001), NYHA class (HR: 3.675, 95%CI: 2.222-6.079, p<0.001) and UA (HR: 1.154, 95%CI: 1.067-1.248, p<0.001) and hs-RCP (HR: 1.091, 95%CI: 1.032-1.153, p<0.001) appear to be important factors to determine the cardiovascular death in CHF patients. The predictive cutoff value of UA levels for cardiovascular death was evaluated in Receiver operating characteristic (ROC) curve analysis. The area under the curve for UA was 0.629 (95% CI, 0.582-0.675; P<0.001). ROC curve analysis showed that 4.65 mg/dL UA level had 93% sensitivity and 86% specificity for cardiovascular death. Conclusıon: Increased UA levels were an independent predictor in CHF. Even slightly increased UA levels could be a predictor for cardiovascular death in patients with CHF. 
